Send to

Choose Destination
Leukemia. 2018 Dec 19. doi: 10.1038/s41375-018-0319-2. [Epub ahead of print]

Single cell analysis of clonal architecture in acute myeloid leukaemia.

Author information

Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
Barts Cancer Institute, Queen Mary University of London, London, UK.
Memorial Sloan Kettering Cancer Center, New York, USA.
Wellcome Sanger Institute, Hinxton, UK.
Royal Marsden Hospital, Sutton, UK.
Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.


We used single cell Q-PCR on a micro-fluidic platform (Fluidigm) to analyse clonal, genetic architecture and phylogeny in acute myeloid leukaemia (AML) using selected mutations. Ten cases of NPM1c mutant AML were screened for 111 mutations that are recurrent in AML and cancer. Clonal architectures were relatively simple with one to six sub-clones and were branching in some, but not all, patients. NPM1 mutations were secondary or sub-clonal to other driver mutations (DNM3TA, TET2, WT1 and IDH2) in all cases. In three of the ten cases, single cell analysis of enriched CD34+/CD33- cells revealed a putative pre-leukaemic sub-clone, undetectable in the bulk CD33+ population that had one or more driver mutations but lacked NPM1c. Cells from all cases were transplanted into NSG mice and in most (8/10), more than one sub-clone (#2-5 sub-clones) transplanted. However, the dominant regenerating sub-clone in 9/10 cases was NPM1+ and this sub-clone was either dominant or minor in the diagnostic sample from which it was derived. This study provides further evidence, at the single cell level, for genetic variegation in sub-clones and stem cells in acute leukaemia and demonstrates both a preferential order of mutation accrual and parallel evolution of sub-clones.

[Available on 2019-06-19]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center